Evidence map›Paper›PMID 33082620›Full record

ArticleAnnals of the National Academy of Medical Sciences (India)2020

Insights into the Immunopathophysiology of Severe COVID-19 in Metabolic Disorders.

Skand Shekhar, Caroline E Copacino, Francisco J Barrera, Janet E Hall, Fady Hannah-Shmouni

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of the National Academy of Medical Sciences (India), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Skand ShekharSection on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Caroline E CopacinoTufts University School of Medicine, Boston, Massachusetts, USA.
Francisco J BarreraEndocrinology Division, Internal Medicine Department, University Hospital "Dr. Jose E. Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
Janet E HallClinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health (NIH), Research Triangle Park, North Carolina, USA.
Fady Hannah-ShmouniSection on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Eunice Kennedy Shriver National Institute of Child Health and Human Development · USMayo Clinic · USNational Institute of Environmental Health Sciences · USNational Institutes of Health · USTufts University · US

Funding

Intramural NIH HHS Z99 HD999999
6 · The paper itself

Abstract

COVID-19 has affected millions of people across the world but disproportionately and severely affects persons with metabolic disorders such as obesity, diabetes mellitus and hypertension. In this brief review, we discuss the pathways of immune dysregulation that may lead to severe COVID-19 in persons with metabolic conditions.

Indexed as

COVID-19Diabetes MellitusHypertensionObesity

Identifiers

PMID33082620
PMCPMC7571615
OpenAlexW3038118074

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.